Methods of treating mucositis using anti-TNF antibodies
US8435526B2 · kind B2 · utility
0Cited by
18References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 20, 2012 |
| Grant date | May 7, 2013 |
| Priority date | — |
| Expiry date | Apr 20, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In accordance with the invention, the development and use of antibodies within the digestive tract is provided. Antibodies are described that are used to treat disorders associated with altered permeability of the digestive tract. Antibodies are described with increased stability within the environment of the digestive tract. Antibodies are described with enhanced permeability to a compromised digestive tract.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.